Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Isolated cerebral post-transplant lymphoproliferative disorder in a lymphoma recipient.

Tang TC, Chuang WY, Chang H.

J Cancer Res Ther. 2013 Jul-Sep;9(3):534-6. doi: 10.4103/0973-1482.119373.

2.

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.

Chen DB, Song QJ, Chen YX, Chen YH, Shen DH.

Int J Hematol. 2013 Jan;97(1):117-24. doi: 10.1007/s12185-012-1244-1. Epub 2012 Dec 20.

PMID:
23255160
3.

[Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].

Chen DB, Wang Y, Song QJ, Shen DH.

Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):607-12. doi: 10.3760/cma.j.issn.0529-5807.2012.09.008. Chinese.

PMID:
23157829
4.

Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation.

Liu QF, Fan ZP, Luo XD, Sun J, Zhang Y, Ding YQ.

Transpl Infect Dis. 2010 Aug 1;12(4):284-91. doi: 10.1111/j.1399-3062.2010.00502.x. Epub 2010 Mar 23.

PMID:
20345506
5.

Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.

J Clin Oncol. 2009 Jul 10;27(20):3354-62. doi: 10.1200/JCO.2008.20.0857. Epub 2009 May 18.

6.

Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder.

Shimizu H, Saitoh T, Koya H, Yuzuriha A, Hoshino T, Hatsumi N, Takada S, Nagaki T, Nojima Y, Sakura T.

Int J Hematol. 2011 Nov;94(5):495-8. doi: 10.1007/s12185-011-0951-3. Epub 2011 Oct 29.

PMID:
22038015
7.

[Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].

Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J.

Zhonghua Yi Xue Za Zhi. 2008 Dec 2;88(44):3123-6. Chinese.

PMID:
19159594
8.

The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.

Yamamoto N, Nishimura N, Takeuchi M, Ito T, Yokozaki H, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Nishio H, Matsuo M, Imadome K, Iijima K.

Eur J Pediatr. 2014 Dec;173(12):1615-8. doi: 10.1007/s00431-013-2181-6. Epub 2013 Oct 30.

PMID:
24169729
9.

Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.

Meyer SC, Medinger M, Halter JP, Baldomero H, Hirsch HH, Tzankov A, Dirnhofer S, Passweg JR, Tichelli A.

Hematology. 2014 Jul;19(5):280-5. doi: 10.1179/1607845413Y.0000000123. Epub 2013 Nov 25.

PMID:
24074746
10.

Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm.

Piccin A, Morello E, Svaldi M, Haferlach T, Facchetti F, Negri G, Vecchiato C, Fisogni S, Pusceddu I, Cortelazzo S.

Hematol Oncol. 2012 Dec;30(4):210-3. doi: 10.1002/hon.2023. Epub 2012 Aug 23.

PMID:
22915052
11.

[Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].

Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.

Acta Med Croatica. 2011 Sep;65 Suppl 1:37-43. Croatian.

PMID:
23126028
12.

Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.

Lieberman F, Yazbeck V, Raptis A, Felgar R, Boyiadzis M.

J Neurooncol. 2012 Apr;107(2):225-32. doi: 10.1007/s11060-011-0739-6. Epub 2011 Oct 26. Review.

PMID:
22037801
13.

Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.

Kinch A, Cavelier L, Bengtsson M, Baecklund E, Enblad G, Backlin C, Thunberg U, Sundström C, Pauksens K.

Am J Transplant. 2014 Dec;14(12):2838-45. doi: 10.1111/ajt.12990. Epub 2014 Oct 10.

14.

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges.

Kittan NA, Beier F, Kurz K, Niller HH, Egger L, Jilg W, Andreesen R, Holler E, Hildebrandt GC.

Transpl Infect Dis. 2011 Oct;13(5):524-30. doi: 10.1111/j.1399-3062.2011.00621.x. Epub 2011 Mar 13.

PMID:
21395956
15.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Styczynski J, Einsele H, Gil L, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):383-92. doi: 10.1111/j.1399-3062.2009.00411.x. Epub 2009 Jun 23. Review.

PMID:
19558376
16.

Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.

Zallio F, Primon V, Tamiazzo S, Pini M, Baraldi A, Corsetti MT, Gotta F, Bertassello C, Salvi F, Rocchetti A, Levis A.

Clin Transplant. 2013 Jul-Aug;27(4):E491-7. doi: 10.1111/ctr.12172. Epub 2013 Jun 19.

PMID:
23781897
17.

The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?

Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.

Pediatr Blood Cancer. 2006 Aug;47(2):200-5.

PMID:
16206207
18.

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.

Gulley ML, Swinnen LJ, Plaisance KT Jr, Schnell C, Grogan TM, Schneider BG; Southwest Oncology Group.

Transplantation. 2003 Sep 27;76(6):959-64.

PMID:
14508361
19.

Thoracic presentations of posttransplant lymphoproliferative disorders.

Halkos ME, Miller JI, Mann KP, Miller DL, Gal AA.

Chest. 2004 Dec;126(6):2013-20.

PMID:
15596707
20.

Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.

Ramalingam P, Rybicki L, Smith MD, Abrahams NA, Tubbs RR, Pettay J, Farver CF, Hsi ED.

Mod Pathol. 2002 Jun;15(6):647-56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk